How this instrument works
CHA₂DS₂-VASc adds eight risk factors linked to stroke risk in atrial fibrillation: congestive heart failure or left ventricular dysfunction (1 point), hypertension (1), age 75 or older (2), diabetes (1), prior stroke, TIA, or thromboembolism (2), vascular disease (1), age 65 to 74 (1), and female sex (1). The total runs from 0 to 9 and is used to help weigh whether the estimated stroke risk justifies anticoagulation.
Age 75 and older and a prior stroke or TIA each carry two points instead of one — not an arbitrary scaling, but a deliberate design choice from the score's derivation by Lip and colleagues, published in Chest in 2010 using data from the Euro Heart Survey on atrial fibrillation. Both factors showed a substantially larger independent association with stroke than the single-point factors in that analysis, so the scoring gives them proportionally more weight. The tool itself refined an earlier score, CHADS2, by adding vascular disease, an intermediate age band, and female sex to catch lower-risk patients CHADS2 tended to miss.
Every factor here is drawn from a patient's recorded history and exam — a heart failure diagnosis, a blood pressure reading, a birth date, prior imaging or events — not something this instrument measures directly. Guidelines commonly use the total to help weigh estimated stroke risk against the bleeding risk of anticoagulation, but that decision also folds in bleeding-risk scores, patient preference, and drug interactions the eight factors alone don't capture. This is decision support next to a clinician's full assessment, not a prescription by itself.
- Toggle Congestive heart failure / LV dysfunction to Yes if either applies.
- Toggle Hypertension and Diabetes mellitus to Yes or No based on the patient's history.
- Toggle Age 75 or older to Yes if it applies — this factor is worth two points.
- Toggle Prior stroke, TIA, or thromboembolism to Yes if any occurred — also worth two points.
- Toggle Vascular disease, Age 65-74, and Female sex as they apply, then read the total, 0 to 9.
Worked example — three totals across the 0-to-9 scale
Heart failure, hypertension, and age 75 or older all present, nothing else: 1 + 1 + 2 = 4 — the double weight on age 75 does the heavy lifting here, since two ordinary one-point factors plus that single two-point factor already reach 4, a total generally supporting a conversation about anticoagulation.
No risk factors present at all: every one-point and two-point factor sits at zero, summing to 0 — the lowest possible score and the band the Chest 2010 derivation associated with the lowest estimated annual stroke risk on the scale.
Every factor present except age 75 or older — heart failure, hypertension, diabetes, prior stroke or TIA, vascular disease, age 65 to 74, and female sex: 1 + 1 + 1 + 2 + 1 + 1 + 1 = 8, near the top of the 0-to-9 range even without the single largest individual contributor being triggered.
Questions
Why do age 75+ and prior stroke count for two points each?
Because in the data Lip and colleagues used to build the score — the Euro Heart Survey on atrial fibrillation, published in Chest in 2010 — both factors carried a substantially larger independent association with stroke than single-point factors like hypertension or diabetes. Doubling their weight was a deliberate choice to reflect that outsized contribution, validated against real outcome data rather than picked as a round number.
What does a CHA₂DS₂-VASc score of 0 mean?
It means none of the eight risk factors were present, placing a patient in the lowest estimated stroke-risk band the score defines. Many guidelines treat a score of 0 in men (or 0-1 in women, since female sex alone contributes a point) as a group where the bleeding risk of anticoagulation may outweigh the modest stroke-risk reduction, though that judgment still belongs to a clinician weighing the individual patient.
How is CHA₂DS₂-VASc different from the older CHADS2 score?
CHADS2 used five factors — heart failure, hypertension, age 75+, diabetes, and prior stroke (worth two points) — on a 0-to-6 scale. CHA₂DS₂-VASc, from later work by much of the same research group, added vascular disease, an intermediate 65-to-74 age band, and female sex, extending the scale to 0-to-9. The extra factors were added specifically to better separate genuinely low-risk patients from the moderate-risk group CHADS2 tended to lump together.
Does a high score mean anticoagulation is mandatory?
No. The score estimates stroke risk, and guidelines use that estimate alongside a separate bleeding-risk assessment, the anticoagulant options available, and the patient's own preferences before recommending treatment. A high total strengthens the case for anticoagulation, but the final call weighs more than these eight factors and belongs with a clinician managing the individual patient's atrial fibrillation.
What counts as vascular disease in this score?
The original derivation defines it as prior myocardial infarction, peripheral artery disease, or a complex aortic plaque seen on imaging — evidence of atherosclerotic disease somewhere beyond the heart's own rhythm. It contributes one point, the same weight as hypertension or diabetes, distinguishing it from the double-weighted age 75+ and prior stroke or TIA factors.
Why does female sex add a point on its own?
In the derivation data, female sex was independently associated with a higher stroke risk once the other seven factors were accounted for, which is why it was kept as a standalone one-point factor rather than folded into another category. Some later guidance treats female sex as a risk modifier rather than a true independent factor in very-low-risk patients, so this single point is often read alongside the rest of a patient's profile rather than on its own.
References
Read this first: This instrument computes a screening figure from population formulas — it is not a diagnosis, and it cannot see the whole picture a clinician can. Use it to inform a conversation, not to replace one.